Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UBE2M | P61081 | 2/20 | 0.48 |
| ▸ | DCUN1D1 | Q96GG9 | 2/20 | 0.48 |
| ▸ | CCR2 | P41597 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | HTR7 | P34969 | 1/20 | 0.41 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14815382 | 0.94 | SIGMAR1 (0.46) | HTR1AHTR7CACNA1BSIGMAR1CHRM3 | |
| SCHEMBL14815229 | 0.90 | UBE2M (0.48) | UBE2MDCUN1D1CCR2HTR1AHTR7 | |
| SCHEMBL14815334 | 0.87 | KCNH2 (0.43) | UBE2MDCUN1D1CCR2HTR1AHTR7 | |
| SCHEMBL14815237 | 0.82 | DRD2 (0.43) | HTR1AHTR7CACNA1BDRD2ADRA1D | |
| SCHEMBL14815148 | 0.79 | DRD2 (0.48) | HTR1AHTR7CACNA1BDRD2ADRA1D | |
| SCHEMBL14815064 | 0.77 | HRH1 (0.45) | CACNA1BDRD2ADRA1DADRA1AADRA1B | |
| SCHEMBL14815095 | 0.75 | CCR2 (0.48) | UBE2MDCUN1D1CCR2HTR1AHTR7 | |
| SCHEMBL14833369 | 0.75 | CCR2 (0.48) | UBE2MDCUN1D1CCR2HTR1AHTR7 | |
| SCHEMBL14815248 | 0.74 | CACNA1B (0.49) | UBE2MDCUN1D1CACNA1B | |
| SCHEMBL14815482 | 0.73 | HSD11B1 (0.51) | UBE2MDCUN1D1CACNA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130085142-A1 | SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS | ABBVIE INC. (US) | 2013-04-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085142-A1 | SUBSTITUTED OCTAHYDROPYRROLO[1,2-a]PYRAZINES AS CALCIUM CHANNEL BLOCKERS | CACNA1C, CACNA1E, CACNA1D | UBE2M 4772/4885DCUN1D1 1024/4885CCR2 2651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.